Albumin

There are 1,710 papers on albumin in aging research: 103 trials and 1,441 observational studies in people, 59 in animals, 4 in cells, 86 reviews.

Biomarker

1,710 papers study it1,778 more mention it326 findings

MeSH

220 new papers in 30 daysSee all 3,488 papers on albumin

At a glance

Higher albumin is associated with lower mortality in older patients with pneumonia or receiving peritoneal dialysis, and with less frailty in geriatric inpatients. An observational study of surgically treated intertrochanteric fractures shows no clear link with one-year mortality. Human trials report albumin increases with nutritional support or resistance training, but no clear change with beta-hydroxy-beta-methylbutyrate.

326 findings in 294 papers from 2002 to 2026, 49 of them since April 2026

“Mortality at 180 days was significantly increased in the low albumin group compared with patients with normal albumin concentrations”
Admission serum albumin concentrations and response to nutritional therapy in hospitalised patients at malnutrition risk: Secondary analysis of a randomised clinical trialEClinicalMedicine2022doi:10.1016/j.eclinm.2022.101301
  • Human trial103
  • Humans1,441
  • Animals59
  • Cells4
  • In silico6

Interventions

38

Omega-3 fatty acids

upin humans2no changein humans1

3 studies
  1. Omega-3 fatty acids increase albumin in patients with CKD undergoing hemodialysis (p = 0.014).

    “However, group that received w-3 showed an improvement in serum albumin levels (p = 0.014)”

    Human trialin patients with CKD undergoing hemodialysiscapsules2g/day8 weeksn = 59

    Omega-3 supplementation effects on cardiovascular risk and inflammatory profile in chronic kidney disease patients in hemodialysis treatment: An intervention study

    Clinical nutrition ESPEN

  2. Omega-3 fatty acids increase albumin in humans (hemodialysis) (P = 0.07).

    “For the omega-3 group, serum albumin was also marginally higher after 6 months as compared to baseline (P = 0.07).”

    Human trialhemodialysisplasma-serum2.4 g omega-3 plus 30 mL protein6 months

    Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients

    Vascular health and risk management

  3. Omega-3 fatty acids showed no clear effect on albumin in humans (patients on hemodialysis) (SMD 0.91 (95% CI -0.78, 2.59)).

    “but did not significantly improve albumin (SMD: 0.91; 95% CI: -0.78, 2.59)”

    Reviewpatients on hemodialysissupplementationn = 371

    The Effect of Omega-3 Supplementation on Serum Levels of Inflammatory Biomarkers and Albumin in Hemodialysis Patients: A Systematic Review and Meta-analysis

    Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation

More on Omega-3 fatty acids

Caloric restriction

downin humans1downin mice1

2 studies
  1. Caloric restriction decreases albumin in humans (-8.6% vs -14.8%).

    “Albumin decreased by 8.6% in the CR group and 14.8% in the CR + Ex group (p ≤ 0.001”

    Human trial6-monthfemalesn = 102

    Effects of caloric restriction and exercise-induced weight loss on physiological dysregulation in postmenopausal women: The mediating role of fat mass and adipose tissue distribution

    The journal of nutrition, health & aging

  2. Caloric restriction decreases albumin in humans (inactive overweight or obese) (from 63.26 ± 51.08 to 56.43 ± 37.38 g/dL).

    “albumin (from 63.26 ± 51.08 to 56.43 ± 37.38 g/dL)”

    Human trialinactive overweight or obese6-monthfemalesn = 102

    Effects of caloric restriction and exercise-induced weight loss on physiological dysregulation in postmenopausal women: The mediating role of fat mass and adipose tissue distribution

    The journal of nutrition, health & aging

  3. Caloric restriction decreases albumin in mice (60% dietary restriction).

    “The present animal model also showed biochemical changes with hypoalbuminemia”

    Animals60% dietary restriction10 weeksmales

    Development of a malnutrition model in mice: Comparative evaluation of food restriction percentage and different diets

    The Journal of nutritional biochemistry

More on Caloric restriction

Resistance training

upin humans2

2 studies
  1. Resistance training increases albumin in humans.

    “albumin (F = 7.214, P =.003; 4 weeks > baseline [Group RT+WP, Group RT+placebo]; 8 weeks > baseline [Group RT+WP, Group RT+placebo]; 8 weeks > 4 weeks [Group RT+WP, Group RT+placebo]; Group RT+WP > Group RT+placebo [8 weeks”

    Human trial8 weeksn = 28

    Effects of nutritional supplement and resistance training for sarcopenia in patients with inflammatory bowel disease: A randomized controlled trial

    Medicine

  2. Resistance training increases albumin in IBD patients with sarcopenia (F = 7.214, P = .003).

    “Both interventions significantly increased albumin (F = 7.214, P = .003).”

    Human trialin IBD patients with sarcopenia8 weeks

    Effects of nutritional supplement and resistance training for sarcopenia in patients with inflammatory bowel disease: A randomized controlled trial

    Medicine

  3. Resistance training increases albumin in maintenance hemodialysis patients (MD = 3.16, 95% CI [1.13-5.19]).

    “serum albumin level (MD = 3.16, 95% CI [1.13-5.19]; P = 0.002) compared with the controls”

    Reviewin maintenance hemodialysis patientsn = 541

    Resistance exercise interventions for sarcopenia and nutritional status of maintenance hemodialysis patients: a meta-analysis

    PeerJ

More on Resistance training

Beta-hydroxy-beta-methylbutyrate

upin humans1no changein humans1

2 studies
  1. Beta-hydroxy-beta-methylbutyrate increases albumin in humans (combined with multicomponent exercise training in older adults with frailty).

    “After 4 weeks, the intervention group showed significantly better total SPPB score, balance score, 6MWT performance, MBI score, and serum albumin level than the control group did (all P < 0.05).”

    Human trialcombined with multicomponent exercise training in older adults with frailtycalcium HMB3 g/d12 weeksn = 136

    Effects of Exercise Training Combined With β-Hydroxy-β-Methylbutyrate Supplementation on Physical Function in Older Adults With Frailty

    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition

  2. Beta-hydroxy-beta-methylbutyrate showed no clear effect on albumin in humans.

    “Statistically significant differences were not observed in the nutritional indicators albumin and prealbumin between the groups, or before and after the intervention (P > 0.05), as demonstrated in Table.”

    Human trialn = 78

    Preliminary clinical study on the synergistic effects of prebiotics and β-hydroxy-β-methylbutyrate in improving muscle function and intestinal barrier function in elderly patients with sarcopenia

    Aging clinical and experimental research

More on Beta-hydroxy-beta-methylbutyrate

Sequential enteral nutrition support

upin humans1

1 study
  1. Sequential enteral nutrition support increases albumin in humans (Δ difference = 4.43 g/L).

    “Compared to the control group, the intervention group had higher levels of ALB (Δ difference = 4.43 g/L), PA (Δ difference = 65.42 mg/L), Hb (Δ difference = 22.67 g/L) and TP (Δ difference = 3.35 g/L) 14 days after intervention”

    Human trial14 days

    Effect of sequential enteral nutrition support on elderly patients with severe ischemic stroke after thrombectomy

    Frontiers in medicine

  2. Sequential enteral nutrition support increases albumin in humans (severe ischemic stroke after thrombectomy) (p < 0.05).

    “higher levels of albumin (ALB), total protein (TP), prealbumin (PA), and hemoglobin (Hb) on the 14th day after intervention (p < 0.05)”

    Human trialsevere ischemic stroke after thrombectomy14th dayn = 115

    Effect of sequential enteral nutrition support on elderly patients with severe ischemic stroke after thrombectomy

    Frontiers in medicine

More on Sequential enteral nutrition support

Multidisciplinary team nursing + high-fiber diet

upin humans1

1 study
  1. Multidisciplinary team nursing + high-fiber diet increases albumin in humans.

    “Compared with the control group, the intervention group had higher ALB and TP levels (p < 0.05, ).”

    Human trial8 weeks

    Effects of multi-disciplinary team nursing model combined with high-fiber dietary intervention on blood glucose level and nutritional status in elderly type 2 diabetes patients: a prospective clinical trial

    Frontiers in medicine

  2. Multidisciplinary team nursing + high-fiber diet increases albumin in humans (type 2 diabetes) (p < 0.05).

    “the ALB and TP levels in the intervention group were higher (p < 0.05)”

    Human trialtype 2 diabetes8 weeks

    Effects of multi-disciplinary team nursing model combined with high-fiber dietary intervention on blood glucose level and nutritional status in elderly type 2 diabetes patients: a prospective clinical trial

    Frontiers in medicine

More on Multidisciplinary team nursing + high-fiber diet

Exercise + nutritional care

upin humans1

1 study
  1. Exercise + nutritional care increases albumin in humans (41.80 ± 5.45 vs 32.25 ± 5.37 g/L).

    “The home-based exercise combined with nutritional care intervention significantly improved key nutritional indicators in the observation group compared to the control group, including albumin, prealbumin, and transferrin levels.”

    Human trial3 monthsn = 126

    Effectiveness of home-based exercise combined with nutritional care intervention in elderly patients with gastric cancer and sarcopenia: a retrospective study

    Frontiers in medicine

  2. Exercise + nutritional care increases albumin in humans (gastric cancer and sarcopenia) (41.80 ± 5.45 g/L vs. 32.25 ± 5.37 g/L, t = 9.905).

    “Following the intervention, the observation group exhibited significantly greater improvements in nutritional biomarkers compared to the control group: albumin (41.80 ± 5.45 g/L vs. 32.25 ± 5.37 g/L, t = 9.905, P < 0.001)”

    Human trialgastric cancer and sarcopenian = 126

    Effectiveness of home-based exercise combined with nutritional care intervention in elderly patients with gastric cancer and sarcopenia: a retrospective study

    Frontiers in medicine

More on Exercise + nutritional care

Mindfulness meditation + progressive muscle relaxation

upin humans1

1 study
  1. Mindfulness meditation + progressive muscle relaxation increases albumin in patients with sarcopenia receiving haemodialysis.

    “When comparing the intervention with the control group, after 12 weeks, the intervention group showed improvements in physical abilities, KDQOLTM scores in the PF, RP, CH, Energy, SPL, SL, DSE, Pain, CF, EWB and PS dimensions, as well as serum inflammation indicators (hs-CRP, IL-1) and nutrition indicators (ALB and PA), and the improvements were significant compared to before the intervention (p < 0.05”

    Human trialin patients with sarcopenia receiving haemodialysis12 weeksn = 49

    The influence of mindfulness meditation combined with progressive muscle relaxation training on the clinical efficacy and quality of life of patients with sarcopenia receiving haemodialysis: a randomised controlled trial

    BMC complementary medicine and therapies

  2. Mindfulness meditation + progressive muscle relaxation increases albumin in humans (patients with sarcopenia receiving maintenance haemodialysis) (30.62 ± 1.65 vs 35.60 ± 1.68; 0.32 ± 0.05 vs 0.44 ± 0.07, p < 0.05).

    “albumin and prealbumin levels were significantly increased compared with the baseline (30.62 ± 1.65 vs 35.60 ± 1.68; 0.32 ± 0.05 vs 0.44 ± 0.07) (p < 0.05)”

    Human trialpatients with sarcopenia receiving maintenance haemodialysis12 weeks

    The influence of mindfulness meditation combined with progressive muscle relaxation training on the clinical efficacy and quality of life of patients with sarcopenia receiving haemodialysis: a randomised controlled trial

    BMC complementary medicine and therapies

More on Mindfulness meditation + progressive muscle relaxation

Multicomponent exercise + branched-chain amino acids

no changein humans1upin humans1

1 study
  1. Multicomponent exercise + branched-chain amino acids showed no clear effect on albumin in humans.

    “In terms of serum albumin, a statistically significant difference in the effect of time was found (F(df: 1949; 46,784) = 3.841, p = 0.02), but no other (time vs. group) significant difference was detected between the albumin levels (p = 0.219).”

    Human trial40 weeksn = 50

    Effect of Training-Detraining Phases of Multicomponent Exercises and BCAA Supplementation on Inflammatory Markers and Albumin Levels in Frail Older Persons

    Nutrients

  2. Multicomponent exercise + branched-chain amino acids increase albumin in humans (frail older persons living at residential care homes).

    “Improvement of cognitive profile and muscle strength-related albumin levels, as well as reduction in the TNF-α levels were found particularly in ME plus BCAAs group”

    Human trialfrail older persons living at residential care homes40 weeksn = 8

    Effect of Training-Detraining Phases of Multicomponent Exercises and BCAA Supplementation on Inflammatory Markers and Albumin Levels in Frail Older Persons

    Nutrients

More on Multicomponent exercise + branched-chain amino acids

Anticholinergic burden

downin humans1

1 study
  1. Anticholinergic burden is linked with lower albumin in humans (high anticholinergic burden (ACB ≥ 2) vs controls (ACB = 0)) (4.08 ± 0.33 vs. 4.38 ± 0.27, p = 0.001).

    “Serum albumin levels were lower in ACB patients comparing to controls (4.08 ± 0.33 vs. 4.38 ± 0.27, p = 0.001).”

    Humanshigh anticholinergic burden (ACB ≥ 2) vs controls (ACB = 0)

    Effect of anticholinergic burden on cardiac functions in older patients

    Zeitschrift fur Gerontologie und Geriatrie

More on Anticholinergic burden

Individualized nutrition therapy

no changein humans1

1 study
  1. Individualized nutrition therapy showed no clear effect on albumin in humans (nursing home setting) (pre: 41.0 g/L post: 40.2 g/L, P =0.175).

    “Serum albumin levels did not change throughout the intervention”

    Human trialnursing home setting10 weeksn = 31

    Nutritional intervention in long-term care facilities: Insights from the GERIKOM cluster-randomized controlled trial and implications for geriatric comorbidities

    Clinical Nutrition Open Science

More on Individualized nutrition therapy

Combined aerobic and resistance training

no changein humans1

1 study
  1. Combined aerobic and resistance training showed no clear effect on albumin in humans (type 2 diabetes without kidney disease).

    “Urinary albumin changes did not differ between groups.”

    Human trialtype 2 diabetes without kidney diseasekidney9 monthsn = 136

    Effect of combined aerobic and resistance training on kidney health in adults with type 2 diabetes: A randomized controlled trial

    Diabetes & metabolic syndrome

More on Combined aerobic and resistance training

Lifestyle modification

upin humans1

1 study
  1. Lifestyle modification increases albumin in humans.

    “an increase in albumin, and the normalization of hematological parameters.”

    Human trial6 monthsn = 100

    Changes of biological age and related biomarkers in the context of a comprehensive geroprotective intervention: results of a prospective follow-up

    CARDIOVASCULAR THERAPY AND PREVENTION

More on Lifestyle modification

Gallic acid

upin humans1

1 study
  1. Gallic acid increases albumin in humans (especially in the trained obese group) (p = 0.043).

    “an increase in albumin was identified in the supplement × time interaction (p = 0.043), especially in the trained obese group.”

    Human trialespecially in the trained obese group200 mg/day12 weeks

    Combined Effects of Gallic Acid Supplementation and Physical Training on Body Composition and Biochemical Parameters in Obese Patients: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

    Nutrients

More on Gallic acid

Fracture liaison service

upin humans1

1 study
  1. Fracture liaison service increases albumin in humans (elderly hip fracture patients).

    “the FLS group showed a significant increase in serum albumin over 1 year (P = 0.022).”

    Human trialelderly hip fracture patients1 year

    Clinical Outcomes of a Coordinator-Based Fracture Liaison Service for Hip Fractures in Korea

    Journal of Korean medical science

More on Fracture liaison service

All 38

Effects

18

Mortality

mediatesin humans2downin humans1HR 0.52

3 studies
  1. Albumin is linked with less mortality in models including laboratory-defined diabetes (HR 0.52 per 1 g/dL, 95% CI 0.30-0.93).

    “Higher serum albumin levels were independently protective in models including laboratory-defined diabetes (HR 0.52 per 1 g/dL, 95% CI 0.30-0.93)”

    Humansin models including laboratory-defined diabetesn = 480

    Prognostic value of serum albumin and inflammatory markers for long-term all-cause mortality across the cardio-kidney-metabolic spectrum: a real-world cohort study

    BMC cardiovascular disorders

  2. Albumin is linked with mortality in humans (mediating effect of metformin on all-cause mortality) (13.32 %, P < 0.0001).

    “relationship between metformin and all-cause mortality risk was partially mediated by ALB, accounting for 13.32 % of the association (P < 0.0001).”

    Humansmediating effect of metformin on all-cause mortality

    Metformin and all-cause mortality in older adults with type 2 diabetes mellitus and hypertension: NHANES 1999-2018 evidence for albumin as a mediator

    Diabetes research and clinical practice

  3. Albumin is linked with mortality in humans (mediating the association between baseline physical activity and mortality) (proportion mediated 54%).

    “Circulation levels of albumin and cholinesterase mediated the association between baseline PA and all-cause mortality (proportion mediated, 54%, both; p < 0.05).”

    Humansmediating the association between baseline physical activity and mortality6-year follow-upn = 441

    Physical activity and all-cause mortality and mediators of the association in the very old

    Experimental gerontology

Sarcopenia

mediatesin humans1downin humans1

2 studies
  1. Albumin is linked with sarcopenia in humans (PFAS-sarcopenia association) (3.48% to 82.42% proportion mediated).

    “liver synthesis function markers (albumin and globin) mediated a substantial proportion of the association, ranging from 3.48% to 82.42%”

    HumansPFAS-sarcopenia associationn = 1,261

    Exposure to Per- and Polyfluoroalkyl Substances and the Risk of Sarcopenia: The Mediating Role of Serum Albumin

    Toxics

  2. Albumin is linked with less sarcopenia in humans (independent association in binary logistic regression) (Exp(B) 0.490, 95% CI 0.281-0.853).

    “Body mass index(BMI), albumin(ALB), fibroblast growth factor 19(FGF19), and tumour necrosis factor alpha(TNF-α) were independent protective factors for sarcopenia”

    Humansindependent association in binary logistic regressionn = 236

    Analysis of prevalence and associated biomarkers of sarcopenia in older adults living in rural community in Wuhan, China

    Frontiers in endocrinology

More on Sarcopenia

Frailty

mediatesin humans2

2 studies
  1. Albumin is linked with frailty in humans (asthma).

    “The mediation analysis revealed that albumin and uric acid were mediators between the OBS and risk of frailty”

    Humansasthman = 3,338

    Relationship of the oxidative balance score with the risk of frailty and mortality in patients with asthma: a mediation analysis of NHANES

    BMC pulmonary medicine

  2. Albumin is linked with frailty in the relationship between DI-GM and frailty (30.34% of total effect).

    “albumin and high-density lipoprotein (HDL) played significant mediating roles in the relationship between DI-GM and frailty, accounting for 30.34 and 9.05% of the total effect, respectively”

    Humansin the relationship between DI-GM and frailty

    The association between the dietary index for gut microbiota and frailty: a cross-sectional study

    Frontiers in nutrition

Survival

downin humans1

1 study
  1. Albumin is linked with lower survival in humans (patients undergoing percutaneous endoscopic gastrostomy) (40 days vs. 776 days (p < 0.001)).

    “Patients with severe hypoalbuminemia (<2.0 g/dL) had a median survival of only 40 days, compared with 776 days in the highest albumin category (≥3.2 g/dL) (p < 0.001).”

    Humanspatients undergoing percutaneous endoscopic gastrostomy

    Pre-procedural nutritional, metabolic, and inflammatory markers associated with survival after percutaneous endoscopic gastrostomy: A retrospective cohort study

    Clinical nutrition ESPEN

Waist circumference

mediatesin humans1

1 study
  1. Albumin is linked with waist circumference in humans (vigorous physical activity and waist circumference) (ACME = 0.885, 95% CI: 0.596 to 1.187, P < 0.001).

    “Mediation analysis showed a significant indirect effect through serum albumin (average causal mediation effect = 0.885, 95% confidence interval: 0.596 to 1.187, P < 0.001)”

    Humansvigorous physical activity and waist circumferencen = 4,882

    Does serum albumin mediate the association between vigorous physical activity and waist circumference? Evidence from NHANES

    Research SquarePreprint

Incident respiratory disease

mediatesin humans1

1 study
  1. Albumin is linked with incident respiratory disease in humans (mediating the association of probable sarcopenia with incident respiratory disease) (2.6%–8.0% of association mediated).

    “with C-reactive protein (5.2 %-12.9 %) and albumin (2.6%-8.0%) showing relatively higher mediation proportions”

    Humansmediating the association of probable sarcopenia with incident respiratory diseasen = 317,628

    Associations of sarcopenia with the risk of incident respiratory disease and the role of inflammation and metabolism: a prospective cohort study

    The journal of nutrition, health & aging

More on Incident respiratory disease

Metabolic dysfunction-associated steatotic liver disease

mediatesin humans1

1 study
  1. Albumin is linked with metabolic dysfunction-associated steatotic liver disease in humans among SFA significantly associated with MASLD (5.9-8.0 %).

    “serum albumin accounted for 5·9-8·0 %”

    Humansamong SFA significantly associated with MASLD

    Association between SFA intake and metabolic dysfunction-associated steatotic liver disease: mediating roles of insulin resistance and serum albumin

    The British journal of nutrition

More on Metabolic dysfunction-associated steatotic liver disease

Chronic obstructive pulmonary disease

mediatesin humans1

1 study
  1. Albumin is linked with chronic obstructive pulmonary disease in humans (Statistical mediation of the CKM-COPD association in the US cohort) (7.5% mediated; p < 0.001).

    “Mediation analyses in the US cohort identified albumin as the strongest mediator (7.5%, p < 0.001)”

    HumansStatistical mediation of the CKM-COPD association in the US cohort

    Association between cardiovascular-kidney-metabolic syndrome and chronic obstructive pulmonary disease: a cross-national analysis from global, US, and Chinese populations

    Respiratory research

More on Chronic obstructive pulmonary disease

Handgrip strength reduction

downin humans1OR 0.714

1 study
  1. Albumin is linked with less handgrip strength reduction in humans (coronary artery disease) (OR 0.714, 95% CI 0.572-0.891).

    “high albumin level (OR 0.714; 95%CI 0.572-0.891) were significantly and negatively associated with reduced handgrip strength”

    Humanscoronary artery disease

    Predicting the occurrence of probable sarcopenia in middle-aged and elderly patients with coronary artery disease: development and validation of a clinical model

    Scientific reports

Cognitive function

mediatesin humans1

1 study
  1. Albumin is linked with cognitive function in humans (relationship between selenium intake and cognition) (3.85% mediation proportion).

    “Albumin and vitamin D significantly mediated the relationship between selenium intake and cognition, and the mediation proportion values of albumin and vitamin D were 3.85% and 8.02%, respectively.”

    Humansrelationship between selenium intake and cognitionn = 2,154

    Mediation Effect of Oxidative Stress on Association Between Selenium Intake and Cognition in American Adults

    Nutrients

All 18

Upstream

4

Age

upin humans1downin rats1

2 studies
  1. Age is linked with higher albumin in humans (older (63.0±4.0 years) versus younger (23.7±2.1 years) adults) (17.1%±12.4% versus 5.0%±9.6%).

    “relative plasma-derived albumin levels were higher (17.1%±12.4%) in the tears of the older, compared with the younger (5.0%±9.6%) group.”

    Humansolder (63.0±4.0 years) versus younger (23.7±2.1 years) adultstear filmn = 30

    Clinical and biochemical analysis of the ageing tear film

    The British journal of ophthalmology

  2. age decreases albumin in rats.

    “in contrast, albumin levels decreased”

    Animalsmales

    Age dependency on some physiological and biochemical parameters of male Wistar rats in controlled environment

    Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering

Centenarians

upin humans1

1 study
  1. Centenarians are linked with higher albumin in humans.

    “Albumin was the most connected hub protein, notably elevated in centenarians compared to younger controls, suggesting a protective role.”

    Humans

    The 'autoimmunome' of centenarians

    Journal of translational autoimmunity

CEBPB

downin human cells1

1 study
  1. CEBPB decreases albumin in HepG2 cells.

    “The CEBP-β inhibition either by a functional inhibitor (i.e., quercetin) or shRNA silencing increased albumin mRNA in HepG2 cells.”

    Cellsin HepG2 cells

    In-vitro evidence indicating that IL-10 causes aging-related hypoalbuminemia via JAK1/STAT3 and CEBP-β

    Experimental cell research

More on CEBPB

IL10

downin human cells1

1 study
  1. IL10 decreases albumin in human cells.

    “We found that IL-10, a paradoxical inflammaging marker, reduced ALB concentration in HepG2 cells.”

    CellsHepG2 cells

    In-vitro evidence indicating that IL-10 causes aging-related hypoalbuminemia via JAK1/STAT3 and CEBP-β

    Experimental cell research

More on IL10

Associations

126

Mortality

downin humans35upin humans22HR 0.26–4.346

57 studies
  1. Albumin raises the risk of mortality in humans (hospitalised medical patients at nutritional risk) (32.4% vs. 22.7%, HR 1.4, 95%CI 1.11 to 1.77, p = 0.005).

    “Mortality at 180 days was significantly increased in the low albumin group compared with patients with normal albumin concentrations”

    Human trialhospitalised medical patients at nutritional risk180 daysn = 1,389

    Admission serum albumin concentrations and response to nutritional therapy in hospitalised patients at malnutrition risk: Secondary analysis of a randomised clinical trial

    EClinicalMedicine

  2. Albumin is associated with mortality in humans (nontuberculous mycobacterial pulmonary disease; low albumin level; multivariate analysis) (Low albumin: HR 3.54, 95% CI 1.60–7.82).

    “Smoking history and low albumin levels were associated with increased all-cause mortality in older adult patients with NTM-PD.”

    Humansnontuberculous mycobacterial pulmonary disease; low albumin level; multivariate analysisn = 110

    Mortality-related prognostic factors in older adult patients with nontuberculous mycobacterial pulmonary disease: A single centre, retrospective cohort study in Japan

    Lung India : official organ of Indian Chest Society

  3. Albumin is associated with mortality in humans (proximal humerus fractures; multivariable Cox regression) (HR 0.26, 95% CI 0.15–0.45).

    “Higher CCI, lower serum albumin, and lower platelet count were independently associated with mortality.”

    Humansproximal humerus fractures; multivariable Cox regressionn = 261

    Mortality Following Proximal Humerus Fractures in Elderly Patients: A Retrospective Cohort Study of Clinical and Laboratory Predictors

    Geriatric orthopaedic surgery & rehabilitation

  4. Albumin is associated with mortality in humans (fragility fracture of the pelvis).

    “Univariable analysis identified significant associations of age, the updated Charlson Comorbidity Index score, and serum albumin level with mortality.”

    Humansfragility fracture of the pelvisn = 46

    Association between the updated Charlson comorbidity index and 1-year mortality after fragility fracture of the pelvis: A prospective observational study

    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association

  5. Albumin is linked with a lower risk of mortality in humans (from the frail state).

    “higher albumin favored recovery from frailty and lowered the frail-to-death intensity”

    Humansfrom the frail state

    Study on frailty trajectories and their association with mortality risk in elderly hemodialysis patients: an analysis based on a multi-state Markov model

    World Economy and Management research

  6. Albumin is linked with a lower risk of mortality in humans (adults with depression) (HR 0.30 (95% CI 0.18–0.49)).

    “each 1-unit increase in albumin level was associated with a HR of 0.30(95% CI,0.18–0.49, p < 0.001) for all-cause mortality”

    Humansadults with depressioneach 1-unit increase89 monthsn = 2,410

    Association of serum albumin with all-cause and cardiovascular mortality among adults with depression

    Research SquarePreprint

  7. Albumin predicts mortality in humans (HR 0.81 per 1 SD).

    “albumin (0.81) carried most of the signal, with smaller contributions from cystatin C, ALT, NLR and hs-CRP”

    Humansper 1 SDmedian 4.4 yearsn = 2,144

    Seven routine blood markers predict five-year mortality in older Indians: a risk score from the LASI-DAD cohort

    Research squarePreprint

  8. Albumin predicts mortality in humans after low-energy femoral neck fracture surgery (58% increase in odds per 1 g/dL decrease).

    “Each 1 g/dL decrease in albumin raised 5-year mortality odds by 58%.”

    Humansafter low-energy femoral neck fracture surgeryeach 1 g/dL decreasen = 427

    Albumin and Ambulatory Status as Predictors of 5-Year Mortality After Low-Energy Femoral Neck Fractures

    Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews

  9. Albumin predicts mortality in humans (90-365 days post-hemiarthroplasty for hip fracture) (OR 0.92 per g/L).

    “For 90-365 days, mortality was associated with age (OR 1.06), higher ASA score (OR 2.60), and lower albumin (OR 0.92 per g/L).”

    Humans90-365 days post-hemiarthroplasty for hip fracture90-365 daysn = 433

    Period-Specific Determinants of Mortality After Geriatric Hip Fracture: Insights into Inflammation, Comorbidity and Surgical Timing

    Geriatric orthopaedic surgery & rehabilitation

  10. Albumin is linked with a lower risk of mortality in humans (critical illness) (OR = .251, 95% CI = 0.111-0.565).

    “serum albumin (odds ratio [OR] = .251, p =0.001, 95% confidence interval [CI] = 0.111-0.565)”

    Humanscritical illnessn = 203

    The impact of inappropriate medication and pressure ulcer on hospital outcomes among geriatric patients with critical illnesses: A prospective cohort study

    Electronic Journal of General Medicine

All 57

Frailty

downin humans27mixedin humans3upin humans1OR 0.17–0.95

31 studies
  1. Albumin is associated with frailty in humans (colorectal cancer patients admitted to the ICU after radical surgery).

    “Higher albumin levels were a protective factor”

    Humanscolorectal cancer patients admitted to the ICU after radical surgeryn = 308

    Preoperative frailty risk in older patients with colorectal cancer admitted to the ICU after surgery: prevalence, associated factors, and association with in-hospital outcomes

    Frontiers in oncology

  2. Albumin is associated with frailty in humans (hospitalized heart failure patients) (aOR 0.92 per 1 g/L increase (95% CI, 0.87–0.97)).

    “lower serum albumin (aOR, 0.92 per 1 g/L increase; 95% CI, 0.87–0.97)”

    Humanshospitalized heart failure patientsn = 461

    Prevalence of frailty and multidimensional associated factors among hospitalized adults with heart failure: a cross-sectional study

    Research SquarePreprint

  3. Albumin is associated with frailty in humans (active IBD) (OR 0.17, 95% CI 0.05-0.59).

    “In multivariate analysis, shorter disease duration (OR = 0.83, 95% CI: 0.70-0.97, p = 0.021) and lower serum albumin levels (OR = 0.17, 95% CI: 0.05-0.59, p = 0.005) were independently associated with frailty”

    Humansactive IBD

    Factors Associated with Frailty in Patients with Active Inflammatory Bowel Disease: A Single-Center Observational Study

    Medicina (Kaunas, Lithuania)

  4. Albumin is associated with frailty in humans (maintenance hemodialysis).

    “Increased age and low albumin level were identified as clinical correlates of frailty.”

    Humansmaintenance hemodialysisn = 391

    Prevalence of frailty in hemodialysis patients and its impact on long-term survival in elderly hemodialysis patients

    Frontiers in medicine

  5. Albumin is associated with frailty in humans (Adjusted analysis) (OR 0.90, 95% CI 0.83–0.99).

    “lower ALB levels (OR = 0.90, 95% CI: 0.83–0.99, P = 0.015)”

    HumansAdjusted analysisn = 2,434

    L-shaped association of plasma creatinine with frailty in oldest‑old: Evidence from a cross-sectional study of CLHLS

    Scientific reports

  6. Frailty is associated with albumin in adults with nondialysis chronic kidney disease.

    “Laboratory findings associated with frailty included lower albumin and hemoglobin, higher blood urea nitrogen, lower bilirubin, reduced globulin, decreased lymphocyte count, and elevated monocyte count.”

    Humansin adults with nondialysis chronic kidney disease

    Frailty, socioeconomic factors, and nutritional biomarkers in patients with nondialysis chronic kidney disease: A cross-sectional analysis

    The Journal of international medical research

  7. Albumin is associated with frailty in humans (chronic kidney disease on hemodialysis).

    “it was found that there is indeed an association between frailty syndrome and albumin.”

    Humanschronic kidney disease on hemodialysisn = 20

    Association between frailty syndrome and albumin in patients with chronic kidney disease on hemodialysis

    Lux Médica

  8. Frailty is associated with albumin in cardiovascular patients (p < 0.05).

    “Frail patients had significantly reduced serum albumin and increased fibrinogen compared to the prefrail and robust groups (p < 0.05).”

    Humansin cardiovascular patientsn = 170

    Combined Fried Frailty Scale and Mini Nutritional Assessment Identifies Cardiovascular Patients with Reduced Protein/Albumin Plasma Levels: A Cross-Sectional Study

    Nutrients

  9. Albumin is associated with frailty in humans (pre-radiotherapy thoracic tumors).

    “Elderly patients who were of advanced age, with multiple chronic diseases, taking multiple medications, engaging in limited resistance exercise, and having low albumin levels are especially vulnerable to frailty.”

    Humanspre-radiotherapy thoracic tumorsn = 139

    Pre-radiotherapy frailty and associated determinants in elderly patients with thoracic tumors

    Translational cancer research

  10. Frailty is associated with albumin in humans (inflammatory bowel disease).

    “Frail individuals also exhibited lower hemoglobin, creatinine, and albumin levels.”

    Humansinflammatory bowel disease53.5% females

    Frailty Prevalence and Evaluation of the FRAIL Scale Questionnaire in Patients with Inflammatory Bowel Disease

    Digestive diseases and sciences

All 31

Sarcopenia

downin humans12upin humans3OR 0.562–2.368

15 studies
  1. Albumin is associated with sarcopenia in humans (newly diagnosed, untreated hypothyroidism) (OR 0.562, 95% CI 0.390–0.809).

    “albumin level (OR=0.562,95%CI 0.390-0.809) and FT3/FT4 ratio (OR=0.514,95%CI 0.360-0.734) were protective factors for sarcopenia (P<0.05).”

    Humansnewly diagnosed, untreated hypothyroidismn = 147

    Analysis of prevalence status and risk factors of sarcopenia in elderly patients with hypothyroidism

    Chinese Journal of Multiple Organ Diseases in the Elderly

  2. Albumin is linked with a lower risk of sarcopenia in humans (multivariate analysis) (OR 0.891, 95% CI 0.773-0.981).

    “albumin (OR: 0.891, 95% CI: 0.773-0.981;p = 0.023) were independent predictors of sarcopenia”

    Humansmultivariate analysisbloodfemalesn = 198

    Immature Granulocyte Percentage in Post-Menopausal Sarcopenic Individuals: A Potential Novel Biomarker?

    European Journal of Geriatrics and Gerontology

  3. Albumin is associated with sarcopenia in humans (OR = 0.777, 95% Cl = 0.693-0.871).

    “lower albumin (OR = 0.777, 95% Cl = 0.693-0.871) levels were associated with an increased risk of sarcopenia.”

    Humansn = 396

    Screening for sarcopenia risk using SARC-F and its relationship with laboratory parameters in primary care

    Scandinavian journal of primary health care

  4. Albumin is associated with sarcopenia in humans (maintenance hemodialysis patients) (PR = 1.80, 95% CI = 1.18-2.74).

    “low serum albumin levels (<35 g/L; P = .007, PR = 1.80, 95% CI = 1.18-2.74)”

    Humansmaintenance hemodialysis patientsn = 106

    Sarcopenia and associated factors in maintenance hemodialysis patients in Vietnam: A cross-sectional study

    Medicine

  5. Sarcopenia is associated with albumin in humans (inpatients with delirium) (p = 0.038).

    “Sarcopenia was associated with lower albumin levels (p = 0.038)”

    Humansinpatients with deliriumn = 57

    Association Between Sarcopenia Measured by Computed Tomography at the Third Lumbar Vertebra and Mortality in Inpatients with Delirium Referred to a Liaison Psychiatry Team: A Follow-Up Study

    Journal of clinical medicine

  6. Sarcopenia is associated with albumin in hospitalized older adults.

    “Serum hemoglobin and albumin levels were reduced in sarcopenic groups”

    Humansin hospitalized older adultsbloodn = 598

    Muscle or Heart? Functional Impact of Sarcopenia and Heart Failure in Geriatric Inpatients

    Journal of clinical medicine

  7. Sarcopenia is associated with albumin in older patients with chronic diseases.

    “Serum irisin, 25(OH)D3, and albumin levels were significantly lower in sarcopenic patients.”

    Humansin older patients with chronic diseases

    Clinical significance of serum irisin, 25(OH)D3 and albumin in older adults with chronic disease and sarcopenia

    Aging clinical and experimental research

  8. Albumin is associated with sarcopenia in humans (Alzheimer's disease).

    “Multivariate regression identified age, low Frailty Rating Scale (FRS) scores, low serum albumin level, and low creatinine/cystatin C ratio (CCR) as risk factors for sarcopenia.”

    HumansAlzheimer's disease

    Identification of risk factors and development of a predictive nomogram for sarcopenia in Alzheimer's disease

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  9. Sarcopenia is associated with albumin in humans (low skeletal muscle mass vs normal) (41.00 vs. 42.50 g/L, p < 0.001).

    “These patients had lower albumin (41.00 vs. 42.50 g/L) and lymphocyte levels (1.60 vs. 2.02 × 109/L) but higher HDL (1.45 vs. 1.16 mmol/L) and calcium levels (2.24 vs. 2.20 mmol/L) (all p < 0.001).”

    Humanslow skeletal muscle mass vs normaln = 1,002

    Development and validation of a predicative model for identifying sarcopenia in Chinese adults using nutrition indicators (AHLC)

    Frontiers in nutrition

  10. Albumin is associated with sarcopenia in humans (community-dwelling adults, adjusted for sociodemographic and other clinical factors) (OR 2.368 (95% CI 1.424-3.939), p < 0.001).

    “having low albumin levels(≤ 4.0 g/dL) were independently associated with sarcopenia i.e. 2.368 times (95% CI 1.424-3.939) in males”

    Humanscommunity-dwelling adults, adjusted for sociodemographic and other clinical factorsmalesn = 2,094

    Serum albumin as a biomarker of (nutritional status in) sarcopenia

    Journal of bone and mineral metabolism

All 15

More on Sarcopenia

1-year mortality

downin humans4upin humans2OR 0.39–0.81

6 studies
  1. Albumin is associated with 1-year mortality in humans (Proximal femur fractures treated surgically; mutually exclusive adjusted regression models).

    “higher NLR and D-dimer levels, lower albumin levels, and a higher composite score were associated with 1-year mortality.”

    HumansProximal femur fractures treated surgically; mutually exclusive adjusted regression models1 yearn = 300

    A composite inflammation-nutrition-coagulation score and 1-year mortality in geriatric proximal femur fractures: a retrospective cohort study

    Archives of orthopaedic and trauma surgery

  2. Albumin is associated with 1-year mortality in humans (OR per 1-g/dL 0.27).

    “and albumin concentration (OR per 1-g/dL 0.27).”

    Humans

    Outcomes of Octogenarians and Nonagenarians in a Contemporary Cardiac Care Unit - Insights From 2,242 Patients Admitted Between 2019 and 2021

    Circulation reports

  3. Albumin is linked with a lower risk of 1-year mortality in humans following hip fracture surgery, admission (OR 0.81, 95% CI 0.75-0.87).

    “albumin (OR 0.81, 95% CI [0.75-0.87]), values at admission were found to be independent predictors of 1-year mortality in elderly patients with hip fracture.”

    Humansfollowing hip fracture surgery, admission

    Predictors of one-year mortality following hip fracture surgery in elderly

    PeerJ

  4. Albumin predicts 1-year mortality in humans (metastatic bladder cancer; albumin<35g/l) (Albumin<35 g/l: adjusted HR 3.06 (95% CI 1.81–5.17)).

    “albumin<35g/l (aHR = 3.06 [1.81-5.17], P = 0.0001)”

    Humansmetastatic bladder cancer; albumin<35g/l1 yearn = 180

    Early chemotherapy discontinuation and mortality in older patients with metastatic bladder cancer: The AGEVIM multicenter cohort study

    Urologic oncology

  5. Albumin is associated with 1-year mortality in humans (Preoperative measurement in patients undergoing hip fracture surgery) (OR 0.39, 95% CI 0.25–0.61).

    “Low preoperative albumin and low body mass index predicted the 6-month and 1-year mortality.”

    HumansPreoperative measurement in patients undergoing hip fracture surgery1 yearn = 772

    C-reactive protein is an independent predictor for 1-year mortality in elderly patients undergoing hip fracture surgery: A retrospective analysis

    Medicine

  6. Albumin predicts 1-year mortality in humans (Albumin <3.3 g/dl after transcatheter aortic valve replacement).

    “Home oxygen use, albumin levels <3.3 g/dl, falls in the past 6 months, STS PROM score >7%, and severe (≥5) Charlson comorbidity score predicted death at 1 year.”

    HumansAlbumin <3.3 g/dl after transcatheter aortic valve replacement1 year

    Predicting Early and Late Mortality After Transcatheter Aortic Valve Replacement

    Journal of the American College of Cardiology

Cognitive impairment

downin humans5OR 0.082–0.95

5 studies
  1. Albumin is associated with cognitive impairment in humans (older adults with cognitive impairment) (OR = 0.53, 95% CI: 0.29–0.97).

    “albumin was associated with reduced odds of cognitive impairment (OR = 0.53, 95% CI: 0.29–0.97)”

    Humansolder adults with cognitive impairmentserumn = 438

    Sex Differences in the Association of Serum Albumin and Cholesterol with Cognitive Function in Older Adults with Cognitive Impairment

    AAIC 2025 abstract

  2. Albumin is associated with cognitive impairment in humans (shared metabolite) (OR = 0.95 [0.92-0.98]).

    “Albumin was identified as the common metabolite shared by the two phenotypes (OR = 0.90[0.85-0.95] for VI, and 0.95[0.92-0.98]) for cognitive impairment).”

    Humansshared metaboliten = 23,775

    Distinct and Overlapping Metabolites Associated with Visual Impairment and Cognitive Impairment

    Journal of Alzheimer's disease reports

  3. Albumin is linked with a lower risk of cognitive impairment in humans (OR = 0.37, 95% CI = 0.15, 0.88).

    “albumin (OR = 0.37, 95% CI = 0.15, 0.88)”

    Humansn = 4,578

    The factors associated with cognitive function among community-dwelling older adults in Taiwan

    BMC geriatrics

  4. Albumin is associated with cognitive impairment in humans (older patients with severe aortic stenosis) (OR 0.082, p = 0.011).

    “Prevalence of cognitive impairment of 15.3%, which was associated with albumin level - odds ratio (OR): 0.082; p = 0.011”

    Humansolder patients with severe aortic stenosisn = 300

    Cognitive impairment in the elderly patient with symptomatic severe aortic stenosis. Therapeutic decisions and impact on one-year mortality

    Revista de neurologia

  5. Albumin is associated with cognitive impairment in humans (chronic heart failure) (OR 0.59 (0.35–0.99)).

    “albumin > 3.5 (OR: 0.59 (0.35-0.99) p = 0.048)”

    Humanschronic heart failuren = 525

    Ischemic aetiology, self-reported frailty, and gender with respect to cognitive impairment in chronic heart failure patients

    BMC cardiovascular disorders

More on Cognitive impairment

In-hospital mortality

downin humans3upin humans1OR 0.75–3.92

4 studies
  1. Albumin predicts in-hospital mortality in humans (emergency surgery for perforated peptic ulcer) (OR 0.75).

    “advanced age (odds ratio [OR] 1.07, p=0.010) and low serum albumin (OR 0.75, p<0.001) were the strongest independent predictors of mortality.”

    Humansemergency surgery for perforated peptic ulcern = 97

    A multidimensional approach to frailty in emergency surgery for perforated peptic ulcer

    Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES

  2. Albumin predicts in-hospital mortality in humans (hospitalized nonagenarians).

    “Equally, decreased albumin level was found to be a mortality predictor.”

    Humanshospitalized nonagenarians

    C-Reactive Protein and Albumin Levels as Useful Tools for Predicting In-Hospital Outcomes in Polish Nonagenarians

    Clinical interventions in aging

  3. Albumin is associated with in-hospital mortality in humans (Acute heart failure; multivariate analysis).

    “and was independently associated with higher serum creatinine levels and lower serum albumin and TC levels.”

    HumansAcute heart failure; multivariate analysisDuring hospitalizationn = 301

    Total cholesterol levels predict in-hospital mortality in patients with acute heart failure aged 70 years or older

    Revista espanola de geriatria y gerontologia

  4. Albumin is associated with in-hospital mortality in humans (Patients requiring prolonged mechanical ventilation; albumin ≤2 g/dL) (OR 3.92, 95% CI 2.17–7.01 for albumin ≤2 g/dL).

    “poor outcomes in this specific population were found to be associated with a higher APACHE II score and lower albumin level.”

    HumansPatients requiring prolonged mechanical ventilation; albumin ≤2 g/dLn = 510

    The Outcomes and Prognostic Factors of the Very Elderly Requiring Prolonged Mechanical Ventilation in a Single Respiratory Care Center

    Medicine

Activities of daily living

upin humans1no changein humans1downin humans1

3 studies
  1. Albumin is associated with activities of daily living in humans (one month after admission).

    “One month after admission, CONUT (correlation coefficient (r) = -0.587, confidence interval (CI) = -0.813 to -0.209) and Alb (r = 0.505, CI = 0.093 to 0.769) showed correlations with FIM improvement.”

    Humansone month after admissionn = 21

    Association Between Nutritional Status and Activities of Daily Living in Super-elderly Patients With Proximal Femoral Fractures After Surgery in a Rehabilitation Ward During the Convalescent Phase

    Cureus

  2. Albumin is associated with activities of daily living in humans (older patients with CKD in the acute phase) (ρ = 0.093, 95% CI -0.12 to 0.30, P = 0.384).

    “albumin (ρ = 0.093; 95% CI, - 0.12 to 0.30; P = 0.384) and CRP level (ρ = - 0.176; 95% CI; - 0.37 to 0.03; P = 0.098) were not significantly correlated with the FIM score at discharge”

    Humansolder patients with CKD in the acute phasen = 89

    Systemic inflammation is associated with reduced functional recovery in older inpatients with chronic kidney disease

    International urology and nephrology

  3. Albumin is associated with activities of daily living in humans (patients admitted to geriatric rehabilitation after acute hospitalization).

    “Lower average albumin, higher albumin variation and lower minimum albumin were associated with larger declines in ADL”

    Humanspatients admitted to geriatric rehabilitation after acute hospitalization56% femalesn = 1,769

    Albumin and C-reactive protein relate to functional and body composition parameters in patients admitted to geriatric rehabilitation after acute hospitalization: findings from the RESORT cohort

    European geriatric medicine

Cognitive impairment

downin humans2upin humans1OR 0.6–1.023

3 studies
  1. Albumin is linked with a lower risk of cognitive impairment in humans after adjusting for potential confounders (OR 0.60, 95% CI 0.41-0.87).

    “a negative association was found between albumin levels and cognitive function (odds ratio [OR] = 0.60, 95% confidence interval [CI] 0.41-0.87).”

    Humansafter adjusting for potential confounders

    Sex and race differences in the association of albumin with cognitive function in older adults

    Brain and behavior

  2. Albumin is associated with cognitive impairment in humans (binary logistic regression) (OR = 1.023, 95%CI: 1.004-1.043, p = 0.011).

    “Binary logistic regression showed that cognitive impairment was significantly associated with age (OR = 0.934, 95%CI: 0.886-0.985, p = 0.017), female sex (OR = 2.255, 95%CI: 1.761-2.888, p < 0.001), lower education level (less than senior high school) (OR = 11.509, 95%CI: 9.064-14.613, p < 0.001), and lower albumin (OR = 1.023, 95%CI: 1.004-1.043, p = 0.011).”

    Humansbinary logistic regressionn = 7,201

    Association of lower liver function with cognitive impairment in the Shenzhen ageing-related disorder cohort in China

    Frontiers in aging neuroscience

  3. Albumin is linked with a lower risk of cognitive impairment in humans (chronic heart failure) (OR = 0.767, P < 0.05).

    “albumin (odds ratio [OR]=0.767, P < 0.05)”

    Humanschronic heart failuren = 184

    Correlation Analysis of Cognitive Impairment And Malnutrition In Elderly Patients With Chronic Heart Failure

    Research SquarePreprint

Malnutrition

downin humans2OR 0.07

2 studies
  1. Malnutrition is associated with albumin in humans (malnutrition or its risk (MNA ≤ 11)) (p < 0.001).

    “lower levels of albumin, total protein, hemoglobin, leptin, 25(OH) D, and IGF-1, and higher levels of C-reactive protein (CRP), NT-proBNP, and ferritin (p < 0.001)”

    Humansmalnutrition or its risk (MNA ≤ 11)n = 3,869

    Clinical and Laboratory Markers of Body Wasting and Malnutrition in Long-Livers

    Russian Journal of Geriatric Medicine

  2. Albumin is linked with a lower risk of malnutrition in humans (nursing home residents) (OR = 0.070).

    “The frailty risk (OR = 3.317), MM (OR = 0.732), PhA (OR = 0.033), serum albumin (OR = 0.070), and EuroQol visual analogue scale (OR = 0.961) were risk predictors of DRM”

    Humansnursing home residentsn = 340

    Assessment of Hidden Nutritional Burden: High Prevalence of Disease-Related Malnutrition in Older Adults Without Cognitive Impairment Living in Nursing Homes in Madrid-A Multicentre Study

    Nutrients

More on Malnutrition

Cognitive function

upin humans2

2 studies
  1. Albumin is associated with cognitive function in humans (older adults with cognitive impairment) (β = 1.74, p = 0.045).

    “albumin levels (β = 1.74, p = 0.045) were positively associated with MMSE scores”

    Humansolder adults with cognitive impairmentserumn = 438

    Sex Differences in the Association of Serum Albumin and Cholesterol with Cognitive Function in Older Adults with Cognitive Impairment

    AAIC 2025 abstract

  2. Albumin is associated with cognitive function in humans (participants aged 80 years).

    “Nutritional status indicators such as serum albumin and frequency of going outdoors were significantly associated with cognitive functioning at age 80 years.”

    Humansparticipants aged 80 years

    Differences in the association between high blood pressure and cognitive functioning among the general Japanese population aged 70 and 80 years: The SONIC study

    Hypertension research : official journal of the Japanese Society of Hypertension

Intrinsic capacity

upin humans1

1 study
  1. Albumin is associated with intrinsic capacity in humans (35.1; 95% CI 23.1-47.2).

    “Changes in NLR, FAI, and serum levels of albumin, DHEA-S, vitamin D were associated with changes in IC over time”

    Human trial12 months

    Enhancing Intrinsic Capacity and Related Biomarkers in Community-Dwelling Multimorbid Older Adults Through Integrated Multidomain Interventions: Ancillary Findings From the Taiwan Integrated Geriatric (TIGER) Trial

    Journal of the American Medical Directors Association

Decreased muscle thickness

upin humans1OR 7.08

1 study
  1. Albumin predicts decreased muscle thickness in humans (low (< 4.1 g/dL) versus normal (≥ 4.1 g/dL) serum albumin) (OR 7.08).

    “participants in the low serum Alb group had an odds ratio of 7.08 for decreased muscle thickness at the AT.”

    Human triallow (< 4.1 g/dL) versus normal (≥ 4.1 g/dL) serum albuminthigh12 weeksn = 69

    Serum albumin levels as a predictive biomarker for low-load resistance training programs' effects on muscle thickness in the community-dwelling elderly Japanese population: interventional study result

    BMC geriatrics

All 126

Funding

4 grants since 2019

National Institute on Aging$666KJapan Society for the Promotion of Science¥8.8M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human studies link lower albumin to higher mortality and greater frailty in older and hospitalized adults, and associate it with walking speed and muscle mass. Human trials report increases with nutritional support and resistance training, decreases with caloric restriction in women, and no change with multicomponent exercise plus branched-chain amino acids.

  2. Summary rewritten as its findings changed.

    As it read before

    Human studies report increased albumin with GLP-1 receptor agonists over 12 months and tirzepatide over 24 weeks in people with type 2 diabetes. A human study associates albumin with mortality following fragility fracture of the pelvis.

  3. Summary written from the findings.

Latest

See all 3,488 papers on albumin